Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - The presentation is led by Revvity's CEO, Prahlad Singh, who highlights the company's progress over the past year [1] - Revvity has undergone a portfolio transformation, evolving from an industrial company with a focus on analytical services, small molecule preclinical life sciences, and diagnostics [3] Financial Overview - The financial figures and growth rates discussed are based on guidance from the 3Q earnings call dated October 27, 2025 [2]